The following post, dating back to June 2005, was one of the first expert interviews I ever published here at the ‘Mine. It was originally titled ‘Surprising Interview with a Joslin Researcher,’ although that title seems quite dated to me now, because the good doctor’s recommendations are so basic (yet still so relevant, and with some great reminders for refreshing your approach in this New Year). I think I was mostly surprised at what he…Read more »
At the end of last year (so, basically, two weeks ago), the Juvenile Diabetes Research Foundation announced a joint partnership with the Johnson & Johnson Corporate Office of Science and Technology to help with the discovery and development of drugs to promote beta cell survival. The program will look to fund research at academic centers around the world that could eventually lead to novel new drugs for the prevention and treatment of type 1 diabetes.
Over the holidays, hubby and I managed to slip away for one-night romantic getaway, and I finally did it! (Check your imaginations at the door, Guys – nothing kinky) I finally decided to enjoy a hot and steamy jacuzzi session without worrying about my OmniPod. Not where it was, or wasn’t, or what was happening to the fragile insulin inside.
This February will mark my three-year anniversary wearing the thing, and I love the freedom…
As a sort of addendum to this Monday’s post, I can’t believe I wrote the following testimonial four whole years ago. Ever more confirmation that the more things change, the more they stay the same:
Sometime in the middle of last week, as I was gazing at my blog banner and mulling over my next post, I had a kind of out-of-body sensation for a moment: Am I still the same person who…Read more »
Dr. Stephen Ponder, who has Type 1 diabetes himself, has been a pediatric endocrinologist for 20 years. He is director of the Children’s Diabetes and Endocrine Center of South Texas at Driscoll Children’s Hospital. He’s also been working with a company called Diabetech on a diabetes monitoring device called GlucoMON for the past several years. Today, he has some big news to report.
But first, for those who are unfamiliar: GlucoMON is “a small, portable…